$27.75
-0.18-0.64%
In chiusura: Nov 17, 4:00 PM EST
$29.33
1.585.69%
Post-mercato: 4:33 PM EST

Zenas BioPharma (ZBIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $-1.65 | $-1.26 | -30.9 % |
| Q2 | Aug 13, 2026 | $-1.77 | $-0.78 | -126.9 % |
| Q1 | May 13, 2026 | $-1.46 | $-1.54 | 5.19 % |
| Q3 | Nov 12, 2025 | $-1.22 | $-0.98 | -24.5 % |
Quarterly Revenue (Billions)
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $1.00M | $27.00M | -96.3 % |
| Q3 | Nov 12, 2025 | $0 | $2.75M | -100.0 % |
| Q2 | Aug 12, 2025 | $0 | $2.75M | -100.0 % |
| Q1 | May 15, 2025 | $10.00M | $1.67M | 498.8 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.26 | $-0.78 | $-1.54 | — |
| Actual | $-1.65 | $-1.77 | $-1.46 | $-4.54 |
| Surprise | -30.9% | -126.9% | +5.19% | — |
| Revenue | ||||
| Estimate | — | $27.0M | — | — |
| Actual | $10.0M | $1.0M | $0 | $0 |
| Surprise | — | -96.3% | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.32 | $-1.40 | $-0.29 | $-1.25 |
| Revenue | ||||
| Consensus | $14.1M | — | — | — |